Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.270
-0.170 (-3.83%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Camp4 Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 222 | 318 | 105 | - | - |
| Market Cap Growth | 424.04% | 202.65% | - | - | - |
| Enterprise Value | 114 | 249 | 274 | - | - |
| Last Close Price | 4.27 | 6.13 | 5.22 | - | - |
| PS Ratio | 63.38 | 90.92 | 161.17 | - | - |
| PB Ratio | 4.65 | 6.67 | 1.66 | - | - |
| P/TBV Ratio | 4.65 | 6.67 | 1.66 | - | - |
| EV/Sales Ratio | 32.64 | 71.22 | 420.77 | - | - |
| Debt / Equity Ratio | 0.04 | 0.04 | 0.14 | 0.32 | 0.15 |
| Net Debt / Equity Ratio | -2.25 | -2.25 | -0.88 | -0.68 | -0.84 |
| Net Debt / EBITDA Ratio | 2.13 | 2.13 | 1.08 | 0.52 | 1.60 |
| Net Debt / FCF Ratio | 3.60 | 3.60 | 1.20 | 0.58 | 1.66 |
| Asset Turnover | 0.04 | 0.04 | 0.01 | 0.00 | - |
| Quick Ratio | 7.07 | 7.07 | 6.68 | 4.97 | 10.56 |
| Current Ratio | 7.35 | 7.35 | 6.92 | 5.13 | 10.62 |
| Return on Equity (ROE) | -145.07% | -145.07% | -101.99% | -80.13% | - |
| Return on Assets (ROA) | -33.18% | -33.18% | -49.80% | -41.17% | - |
| Return on Capital Employed (ROCE) | -50.90% | -50.90% | -77.30% | -110.10% | -47.60% |
| Earnings Yield | -36.27% | -25.28% | -49.29% | - | - |
| FCF Yield | -13.46% | -9.38% | -43.78% | - | - |
| Buyback Yield / Dilution | -547.76% | -547.76% | -1087.44% | -26.47% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.